CYPROTEX Trademark

Trademark Overview


On Thursday, May 28, 2020, a trademark application was filed for CYPROTEX with the United States Patent and Trademark Office. The USPTO has given the CYPROTEX trademark a serial number of 79291031. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by Cyprotex Discovery Limited. The CYPROTEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; contract research organization services (CRO) for pharmaceutical, biotechnology, agrochemical and chemical industries, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes and research and development of new products; screening of chemical compounds being testing of chemicals; testing of chemical compounds; absorption, distribution, metabolism, excretion and toxicology testing of chemical compounds; data analysis of pharmacokinetic properties being testing of pharmaceuticals; computer based predictive methods, namely, testing of pharmaceuticals; provision of scientific information in the field pharmacokinetics; molecular and physiological mathematical modelling being computer modeling services
cyprotex

General Information


Serial Number79291031
Word MarkCYPROTEX
Filing DateThursday, May 28, 2020
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6375243
Registration DateTuesday, June 8, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements


Goods and ServicesPharmaceutical research and development; contract research organization services (CRO) for pharmaceutical, biotechnology, agrochemical and chemical industries, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes and research and development of new products; screening of chemical compounds being testing of chemicals; testing of chemical compounds; absorption, distribution, metabolism, excretion and toxicology testing of chemical compounds; data analysis of pharmacokinetic properties being testing of pharmaceuticals; computer based predictive methods, namely, testing of pharmaceuticals; provision of scientific information in the field pharmacokinetics; molecular and physiological mathematical modelling being computer modeling services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 7, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCyprotex Discovery Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameCyprotex Discovery Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameCyprotex Discovery Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, October 25, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 28, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 28, 2021FINAL DISPOSITION PROCESSED
Wednesday, September 8, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Monday, March 22, 2021NOTIFICATION PROCESSED BY IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 3, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 12, 2021EXAMINER'S AMENDMENT ENTERED
Friday, February 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 12, 2021EXAMINERS AMENDMENT E-MAILED
Friday, February 12, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 19, 2020REFUSAL PROCESSED BY IB
Monday, September 28, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 28, 2020REFUSAL PROCESSED BY MPU
Tuesday, September 8, 2020NON-FINAL ACTION MAILED
Monday, September 7, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, September 6, 2020NON-FINAL ACTION WRITTEN
Sunday, September 6, 2020NON-FINAL ACTION WRITTEN
Sunday, September 6, 2020NON-FINAL ACTION WRITTEN
Sunday, September 6, 2020NON-FINAL ACTION WRITTEN
Friday, August 28, 2020ASSIGNED TO EXAMINER
Tuesday, August 11, 2020APPLICATION FILING RECEIPT MAILED
Friday, August 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB